🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are urged to message these accounts privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Response and Content Elimination

According to TikTok, the platform has removed problematic content and banned related keywords and query recommendations. The organization said it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Research also found communities with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or administering at home.

Within moments of joining one community, a seller posted contact information, where most transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, health issues or past usage.

Item Information and Pricing

Within these communities, posts display dark colored packages with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a injector should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service said it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen patients injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially significant health risks”.